NDC 0078-0827 – Beovu
Brolucizumab 6 mg/.05mL · Injection, Solution · Intravitreal
Product NDC0078-0827
Product details
- Brand name
- Beovu
- Generic name
- Brolucizumab
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- Injection, Solution
- Route
- Intravitreal
- Marketing category
- BLA · BLA761125
- Marketed since
- October 7, 2019
- Listing expires
- December 31, 2026
Active ingredients
- Brolucizumab 6 mg/.05mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0078-0827-60 | 1 SYRINGE, GLASS in 1 CARTON (0078-0827-60) / .05 mL in 1 SYRINGE, GLASS | Mar 9, 2022 |
| 0078-0827-98 sample | 1 SYRINGE, GLASS in 1 CARTON (0078-0827-98) / .05 mL in 1 SYRINGE, GLASS | Mar 9, 2022 |